Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

Syed Tabish R Zaidi; Brett Janson

doi:10.1007/978-3-319-44034-7_7

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

Syed Tabish R Zaidi
, Brett Janson

Pharmacy

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review

Abstract

Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides , lipopeptides , linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.

Original language	English
Title of host publication	Drug Dosing in Obesity: Volume I: Antimicrobials
Editors	Syed Tabish R Zaidi, Jason A Roberts
Place of Publication	Switzerland
Pages	63-76
Edition	1
DOIs	https://doi.org/10.1007/978-3-319-44034-7_7
Publication status	Published - 31 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-3-319-44034-7_7

https://hdl.handle.net/1959.11/73057

Handle.net

Persistent link

Cite this

@inbook{80d6115455f047a9abe8a311fad092ef,

title = "Glycopeptides and Antibiotics for Gram-positive Bacterial Infections",

abstract = "Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides , lipopeptides , linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.",

author = "Zaidi, \{Syed Tabish R\} and Brett Janson",

year = "2016",

month = dec,

day = "31",

doi = "10.1007/978-3-319-44034-7\_7",

language = "English",

isbn = "9783319440323",

pages = "63--76",

editor = "Zaidi, \{Syed Tabish R\} and Roberts, \{Jason A\}",

booktitle = "Drug Dosing in Obesity: Volume I: Antimicrobials",

edition = "1",

}

TY - CHAP

T1 - Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

AU - Zaidi, Syed Tabish R

AU - Janson, Brett

PY - 2016/12/31

Y1 - 2016/12/31

N2 - Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides , lipopeptides , linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.

AB - Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides , lipopeptides , linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.

UR - https://doi.org/10.1007/978-3-319-44034-7

U2 - 10.1007/978-3-319-44034-7_7

DO - 10.1007/978-3-319-44034-7_7

M3 - Chapter

SN - 9783319440323

SN - 9783319440347

SN - 9783319829654

SP - 63

EP - 76

BT - Drug Dosing in Obesity: Volume I: Antimicrobials

A2 - Zaidi, Syed Tabish R

A2 - Roberts, Jason A

CY - Switzerland

ER -

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

Abstract

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this